BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17203754)

  • 1. A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.
    Fiorentini G; Giovanis P; Rossi S; Dentico P; Paola R; Turrisi G; Bernardeschi P
    In Vivo; 2006; 20(6A):721-4. PubMed ID: 17203754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study.
    Fiorentini G; Sarti D; Milandri C; Dentico P; Mambrini A; Fiorentini C; Mattioli G; Casadei V; Guadagni S
    Integr Cancer Ther; 2019; 18():1534735418812691. PubMed ID: 30580645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pattern of care of high-grade gliomas].
    Laigle-Donadey F; Sanson M
    Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of an early postoperative interstitial-hyperthermia combination therapy in malignant gliomas].
    Stahl H; Wust P; Maier-Hauff K; Seebass M; Mischel M; Gremmler M; Golde G; Löffel J; Felix R
    Strahlenther Onkol; 1995 Sep; 171(9):510-24. PubMed ID: 7570300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma.
    Massimino M; Gandola L; Luksch R; Spreafico F; Riva D; Solero C; Giangaspero F; Locatelli F; Podda M; Bozzi F; Pignoli E; Collini P; Cefalo G; Zecca M; Casanova M; Ferrari A; Terenziani M; Meazza C; Polastri D; Scaramuzza D; Ravagnani F; Fossati-Bellani F
    Neuro Oncol; 2005 Jan; 7(1):41-8. PubMed ID: 15701281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
    Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
    Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.
    Bower M; Newlands ES; Bleehen NM; Brada M; Begent RJ; Calvert H; Colquhoun I; Lewis P; Brampton MH
    Cancer Chemother Pharmacol; 1997; 40(6):484-8. PubMed ID: 9332462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
    Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
    J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
    Clavo B; Robaina F; Jorge IJ; Cabrera R; Ruiz-Egea E; Szolna A; Otermin E; Llontop P; Carames MA; Santana-Rodríguez N; Sminia P
    Integr Cancer Ther; 2014 Nov; 13(6):513-9. PubMed ID: 25228535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gliomas in adults: primary non-surgical treatment].
    Poulsen HS
    Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiofrequency hyperthermia in malignant brain tumors: clinical trials].
    Tanaka R
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1370-5. PubMed ID: 3289497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
    Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study.
    Jaeckle KA; Hess KR; Yung WK; Greenberg H; Fine H; Schiff D; Pollack IF; Kuhn J; Fink K; Mehta M; Cloughesy T; Nicholas MK; Chang S; Prados M;
    J Clin Oncol; 2003 Jun; 21(12):2305-11. PubMed ID: 12805331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.